MUMBAI, India, July 31 -- Intellectual Property India has published a patent application (202411098140 A) filed by Council Of Scientific And Industrial Research An Indian Registered Body Incorporated Under The Regn. Of Soc. Act Act Xxi Of on December 10, 2024, for (e)-5-Alkoxy-1-Phenylpentan-1-One O-(2-(n,n-Disubstitutedamino)ethyl) Oximes And Their Therapeutic Use For Covid-19 Disease.
Inventors include Muneer-Ul-Shafi Bhat; Danish Mushtaq; Rayees Ahmad Naikoo; Faheem Fayaz; Ghazala Khanum; Sourav Kumar; Riyaz Ahmed; Alna Kuriyickal Martin; Yogesh Sardana; Renuga Devi; Bokara Kiran Kumar; Qazi Naveed Ahmed; Parvinder Pal Singh; Zabeer Ahmed; and Bhahwal Ali Shah.
The application for the patent was published on July 24, 2026, under issue no. 30/2026.
Abstract: ABSTRACT (E)-5-alkoxy-1-phenylpentan-1-one O-(2-(N,N-disubstitutedamino)ethyl) oximes and their therapeutic use for COVID-19 disease The present invention relates to the simple and economical route of (E)-5-alkoxy-1- phenylpentan-1-one O-(2-(N,N-disubstitutedamino)ethyl) oximes and the methods of preparation thereof. The present invention describes the (E)-5-alkoxy-1-phenylpentan-1-one O-(2-(N,N- disubstitutedamino)ethyl) oximes as potent anti-COVID-19 agents
Disclaimer: Curated by HT Syndication.
